Technical Analysis for ILMN - Illumina, Inc.

Grade Last Price % Change Price Change
C 147.19 -0.29% -0.43
ILMN closed down 2.56 percent on Tuesday, November 12, 2024, on 1.19 times normal volume.
7 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Down

Date Alert Name Type % Chg
MACD Bearish Signal Line Cross Bearish -0.29%
20 DMA Support Bullish -0.29%
Multiple of Ten Bearish Other -0.29%
NR7 Range Contraction -2.84%
Multiple of Ten Bullish Other -2.84%
Inside Day Range Contraction -2.84%
Upper Bollinger Band Walk Strength -2.58%
Multiple of Ten Bullish Other -2.58%
Overbought Stochastic Strength -2.58%
New 52 Week Closing High Bullish -5.13%

   Recent Intraday Alerts

Alert Time
Fell Below 20 DMA 4 minutes ago
Down 3% about 18 hours ago
Down 1 ATR about 18 hours ago
Fell Below 20 DMA about 18 hours ago
Down 2 % about 19 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Illumina, Inc. Description

Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for the analysis of genetic variation and biological function in North America, Europe, Latin America, the Asia-Pacific, the Middle East, and South Africa. Its sequencing platforms include HiSeq 2000, an instrument for high-throughput sequencing using sequencing by synthesis (SBS) technology; HiSeq 1500 that accommodates lower throughput needs; and MiSeq Personal Sequencing System that offers sequencing applications in a compact and economical instrument for individual researchers. The company's sequencing/array combination platforms comprise HiScanSQ that combines SBS technology and HiScan microarray analysis instrumentation into one system. Its array platforms consist of HiScan and iScan systems that are array scanners, which support the imaging of its array-based genetic analysis products. The company also offers various sample preparation and sequencing kits, such as standard sequencing kits; Infinium assay kits; paired-end genomic deoxyribonucleic acid (DNA) sample prep kits; and TruSeq SBS sequencing kits, as well as library preparation kits. In addition, it provides InfiniumHD Whole-Genome BeadChips, which are multi-sample DNA analysis microarrays; HumanOmni5-Quad, HumanOmni2.5, and HumanOmni1S BeadChips; agriculturally relevant genome panels; and iSelect Custom Genotyping BeadChips. Further, it offers CytoChip, a test for the investigation of genetic abnormalities associated with developmental delay or with complex leukemia's; Eco Real-Time polymerase chain reaction system; and sequencing and genotyping services. The company serves genomic research centers, academic institutions, government laboratories, and clinical research organizations, as well as pharmaceutical, biotechnology, agri-genomics, and consumer genomics companies. It sells its products directly and through distributors. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California.


Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Biotechnology Life Sciences Nasdaq 100 Biology Acid Imaging Molecular Biology Telehealth Telemedicine Genomics Clinical Research Lab Testing Scanner Genome DNA Sequencing Genotyping Polymerase Chain Reaction Life Science Tools

Is ILMN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 156.66
52 Week Low 92.69
Average Volume 1,767,091
200-Day Moving Average 127.20
50-Day Moving Average 138.84
20-Day Moving Average 147.31
10-Day Moving Average 150.72
Average True Range 5.03
RSI (14) 52.83
ADX 18.76
+DI 19.00
-DI 18.67
Chandelier Exit (Long, 3 ATRs) 141.56
Chandelier Exit (Short, 3 ATRs) 155.80
Upper Bollinger Bands 155.85
Lower Bollinger Band 138.77
Percent B (%b) 0.52
BandWidth 11.59
MACD Line 3.49
MACD Signal Line 3.76
MACD Histogram -0.27
Fundamentals Value
Market Cap 23.44 Billion
Num Shares 159 Million
EPS -7.35
Price-to-Earnings (P/E) Ratio -20.08
Price-to-Sales 5.05
Price-to-Book 3.81
PEG Ratio 3.79
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 156.05
Resistance 3 (R3) 156.47 154.08 154.65
Resistance 2 (R2) 154.08 151.93 153.87 154.18
Resistance 1 (R1) 150.85 150.61 149.66 150.43 153.71
Pivot Point 148.46 148.46 147.86 148.25 148.46
Support 1 (S1) 145.23 146.31 144.04 144.81 141.53
Support 2 (S2) 142.84 144.99 142.63 141.06
Support 3 (S3) 139.61 142.84 140.60
Support 4 (S4) 139.19